Abiopharma

News list

Montano Maricel Perea 🟢 acquired 66.7K shares (1 derivative) of XOMA Royalty Corp (XOMA) Transaction Date: Mar 11, 2026 | Filing ID: 003283

Full text

News bot March 13, 2026, 11:09 p.m.
🔍 Montano Maricel Perea (Executive)

Company: XOMA Royalty Corp (XOMA)

Report Date: 2026-03-11
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 66,733
Detailed Transactions and Holdings:
- Acquired 26,289 shares of Common Stock (Direct)
  Date: 2026-03-11 | Code: A | equity_swap_involved: false | shares_owned_after: 38,423.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 40,444 shares of Performance Stock Units (Derivative)
  Date: 2026-03-11 | Code: A | equity_swap_involved: false | shares_owned_after: 40,444.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2
Footnotes:
- F1: Represents a grant of restricted stock units payable solely in common stock that will vest as to 25% on each of the first four anniversaries of March 11, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date.
- F2: Each performance stock unit ("PSU") represents a contingent right to receive one share of common stock. The PSUs vest upon the common stock achieving a specified price per share, subject to the Reporting Person's continued service to the Issuer through each vesting date.